ANI PharmaceuticalsANIP
那斯達克 · USD
71.23
-0.76
(-1.06%)
收盤 09/05 03:58 (UTC+8)
09/05 03:58 (UTC+8)
ANI PharmaceuticalsANIP
71.23
-0.76
(-1.06%)
財務數據
損益表
- 1.37
- 1.38
- 1.48
- 1.91
- 1.97
- 2.11
- 2.28
- 2.47
- 2.37
- 2.66
- 4.39
- 0.44
- 7.46
- 28.48
- 3.44
- 7.23
- 7.78
- 8.45
- -3.88
- 12.04
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 266,044 | 237,462 | 247,060 | 227,813 | 211,371 | 197,122 | 190,574 | 148,332 | 138,040 | 137,430 |
營業成本 | 100,158 | 93,582 | 100,269 | 93,389 | 74,615 | 73,037 | 80,280 | 63,075 | 57,698 | 49,157 |
營業毛利 | 165,886 | 143,880 | 146,791 | 134,424 | 136,756 | 124,085 | 110,294 | 85,257 | 80,342 | 88,273 |
營業費用 | 125,426 | 104,992 | 111,937 | 97,889 | 122,864 | 97,891 | 114,672 | - | - | - |
研發費用 | 14,747 | 10,600 | 12,261 | 12,304 | 16,535 | 10,564 | 16,646 | 10,128 | 7,296 | 10,511 |
推銷及管理費用 | 91,039 | 73,473 | 77,063 | 62,186 | 83,048 | 64,436 | 67,826 | 79,900 | 53,180 | 48,111 |
非經常性項目費用 | - | - | - | 767 | - | - | 7,600 | - | - | - |
其他營業費用 | 19,640 | 20,919 | 22,613 | 22,632 | 23,281 | 22,891 | 22,600 | 15,748 | 14,697 | 14,686 |
營業利益 | 40,460 | 38,888 | 34,767 | 36,240 | 13,892 | 26,194 | -4,378 | -20,519 | 5,169 | 20,312 |
其他收入及費用 | -468 | -651 | 763 | -1,148 | 1,739 | 198 | -1,378 | -10,003 | -88 | 5,315 |
利息費用 | 3,636 | 3,769 | 4,411 | 4,727 | 5,438 | 5,484 | 6,015 | 2,331 | 4,656 | 4,600 |
稅前純益 | 37,097 | 40,221 | 31,479 | 33,800 | 10,525 | 19,987 | -13,762 | -31,498 | -2,287 | 25,335 |
所得稅 | 12,386 | 10,729 | 3,989 | 7,183 | 1,976 | 4,306 | -3,486 | -7,332 | - | 7,128 |
稅後純益 | 24,711 | 29,492 | 27,490 | 26,617 | 8,549 | 15,681 | -10,276 | -24,166 | -2,287 | 18,207 |
基本每股稅後盈餘(元) | 1.09 | 1.31 | 1.24 | 1.19 | 0.37 | 0.70 | -0.55 | -1.27 | -0.14 | 0.84 |
稀釋每股稅後盈餘(元) | 1.04 | 1.28 | 1.17 | 1.10 | 0.36 | 0.69 | -0.55 | -1.19 | -0.12 | 0.82 |
基本平均股數(千股) | 21158.00 | 20914.00 | 20686.00 | 20074.00 | 19834.00 | 19607.00 | 19445.00 | 19404.00 | 19321.00 | 19099.00 |
稀釋平均股數(千股) | 21915.00 | 21544.00 | 21774.00 | 21093.00 | 20308.00 | 20046.00 | 19445.00 | 19404.00 | 19321.00 | 19422.00 |
還原基本每股稅後盈餘(元) | 1.09 | 1.31 | 1.24 | 1.19 | 0.37 | 0.70 | -0.55 | -1.27 | -0.14 | 0.84 |
還原稀釋每股稅後盈餘(元) | 1.04 | 1.28 | 1.17 | 1.10 | 0.36 | 0.69 | -0.55 | -1.19 | -0.12 | 0.82 |
還原基本平均股數(千股) | 21,158 | 20,914 | 20,686 | 20,074 | 19,834 | 19,607 | 19,445 | 19,404 | 19,321 | 19,099 |
還原稀釋平均股數(千股) | 21,915 | 21,544 | 21,774 | 21,093 | 20,308 | 20,046 | 19,445 | 19,404 | 19,321 | 19,422 |
EBITDA(千元) | 60,373 | 64,909 | 58,503 | 61,159 | 39,244 | 48,362 | 25,228 | -10,195 | 17,066 | 44,621 |